LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Conference proceedings: WHO implementation workshop on guidelines on procedures and data requirements for changes to approved biotherapeutic products, Seoul, Republic of Korea, 25–26 June 2019

    Wadhwa, Meenu / Kang, Hye-Na / Jivapaisarnpong, Teeranart / Ahmed, Aziza / Andalucia, Lucia Rizka / Blades, Carolina Damas Rocha Zarate / Casas Levano, Mary / Chang, Weihong / Chew, Jing Yin / Chilufya, Mumbi Bernice / Chirachanakul, Parichard / Cho, Heeyoun (Gloria) / Cho, Yi O / Choi, Kyung Min / Chong, Sannie / Chua, Hui Ming / Farahani, Ali Vasheghani / Gencoglu, Mumun / Ghobrial, Mariam Raouf Wefky /
    Guha, Prasunkumar / Gutierrez Lugo, Maria-Teresa / Ha, Sung Bae / Habahbeh, Suna / Hamel, Hugo / Hong, Yeosun / Iarutkin, Aleksei / Jang, Hyunsook / Jayachandran, Ramalingam / Kim, Dong-young / Kim, Gi Hyun / Kim, Yunjeong / Kwon, Hyuk-Sang / Larsen, Jacob / Lee, Aileen HyoJu / Lee, Jiyoung / Medvedeva, Ksenia / Munkombwe, Zuma / Oh, IlUng / Park, Jooyoung / Putri, Desi Eka / Rodgers, Jacqueline / Ryu, Sungmun / Savkina, Maria / Schreitmueller, Thomas / Semeniuk, Oleh / Seo, Mira / Shin, Yung In / Shin, Jinho / Srivastava, Shraddha / Song, HyeonHo / Song, Suwon / Tavares Neto, João / Yamaguchi, Teruhide / Youn, Hyun-Jun (David) / Yun, Minae

    Biologicals. 2020 May, v. 65

    2020  

    Abstract: The first global workshop on implementation of the WHO guidelines on procedures and data requirements for changes to approved biotherapeutic products adopted by the WHO Expert Committee in 2018 was held in June 2019. The workshop participants recognized ... ...

    Institution WHO implementation workshop on guidelines on procedures and data requirements for changes to approved biotherapeutic products
    Abstract The first global workshop on implementation of the WHO guidelines on procedures and data requirements for changes to approved biotherapeutic products adopted by the WHO Expert Committee in 2018 was held in June 2019. The workshop participants recognized that the principles based on sound science and the potential for risk, as described in the WHO Guidelines on post-approval changes, which constitute the global standard for product life-cycle management are providing clarity and helping national regulatory authorities in establishing guidance while improving time-lines for an efficient regulation of products. Consequently, the regulatory situation for post-approval changes and guideline implementation is changing but there is a disparity between different countries. While the guidelines are gradually being implemented in some countries and also being considered in other countries, the need for regional workshops and further training on post-approval changes was a common theme reiterated by many participants. Given the complexities relating to post-approval changes in different regions/countries, there was a clear understanding among all participants that an efficient approach for product life-cycle management at a national level is needed to ensure faster availability of high standard, safe and efficacious medicines to patients as per the World Health Assembly Resolution 67.21.
    Keywords World Health Organization ; guidelines ; patients ; product life cycle ; risk ; South Korea
    Language English
    Dates of publication 2020-05
    Size p. 50-59.
    Publishing place Elsevier Ltd
    Document type Article ; Conference proceedings
    ZDB-ID 1017370-5
    ISSN 1095-8320 ; 1045-1056
    ISSN (online) 1095-8320
    ISSN 1045-1056
    DOI 10.1016/j.biologicals.2019.12.008
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  2. Article ; Online: WHO implementation workshop on guidelines on procedures and data requirements for changes to approved biotherapeutic products, Seoul, Republic of Korea, 25-26 June 2019.

    Wadhwa, Meenu / Kang, Hye-Na / Jivapaisarnpong, Teeranart / Andalucia, Lucia Rizka / Blades, Carolina Damas Rocha Zarate / Casas Levano, Mary / Chang, Weihong / Chew, Jing Yin / Chilufya, Mumbi Bernice / Chirachanakul, Parichard / Cho, Heeyoun Gloria / Cho, Yi O / Choi, Kyung Min / Chong, Sannie / Chua, Hui Ming / Farahani, Ali Vasheghani / Gencoglu, Mumun / Ghobrial, Mariam Raouf Wefky / Guha, Prasunkumar /
    Gutierrez Lugo, Maria-Teresa / Ha, Sung Bae / Habahbeh, Suna / Hamel, Hugo / Hong, Yeosun / Iarutkin, Aleksei / Jang, Hyunsook / Jayachandran, Ramalingam / Kim, Dong-Young / Kim, Gi Hyun / Kim, Yunjeong / Kwon, Hyuk-Sang / Larsen, Jacob / Lee, Aileen HyoJu / Lee, Jiyoung / Medvedeva, Ksenia / Munkombwe, Zuma / Oh, IlUng / Park, Jooyoung / Putri, Desi Eka / Rodgers, Jacqueline / Ryu, Sungmun / Savkina, Maria / Schreitmueller, Thomas / Semeniuk, Oleh / Seo, Mira / Shin, Yung In / Shin, Jinho / Srivastava, Shraddha / Song, HyeonHo / Song, Suwon / Tavares Neto, João / Yamaguchi, Teruhide / Youn, Hyun-Jun David / Yun, Minae

    Biologicals : journal of the International Association of Biological Standardization

    2020  Volume 65, Page(s) 50–59

    Abstract: The first global workshop on implementation of the WHO guidelines on procedures and data requirements for changes to approved biotherapeutic products adopted by the WHO Expert Committee in 2018 was held in June 2019. The workshop participants recognized ... ...

    Abstract The first global workshop on implementation of the WHO guidelines on procedures and data requirements for changes to approved biotherapeutic products adopted by the WHO Expert Committee in 2018 was held in June 2019. The workshop participants recognized that the principles based on sound science and the potential for risk, as described in the WHO Guidelines on post-approval changes, which constitute the global standard for product life-cycle management are providing clarity and helping national regulatory authorities in establishing guidance while improving time-lines for an efficient regulation of products. Consequently, the regulatory situation for post-approval changes and guideline implementation is changing but there is a disparity between different countries. While the guidelines are gradually being implemented in some countries and also being considered in other countries, the need for regional workshops and further training on post-approval changes was a common theme reiterated by many participants. Given the complexities relating to post-approval changes in different regions/countries, there was a clear understanding among all participants that an efficient approach for product life-cycle management at a national level is needed to ensure faster availability of high standard, safe and efficacious medicines to patients as per the World Health Assembly Resolution 67.21.
    MeSH term(s) Biological Products/standards ; Drug Approval ; Drug Evaluation/standards ; Drug and Narcotic Control ; Guidelines as Topic ; Humans ; Seoul ; World Health Organization
    Chemical Substances Biological Products
    Language English
    Publishing date 2020-01-17
    Publishing country England
    Document type Clinical Conference ; Journal Article
    ZDB-ID 1017370-5
    ISSN 1095-8320 ; 1045-1056
    ISSN (online) 1095-8320
    ISSN 1045-1056
    DOI 10.1016/j.biologicals.2019.12.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top